For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate
Give hair three to six months before judging density, since hair needs time to grow above the scalp
Pregnant women and those who are breastfeeding are generally advised to avoid semaglutide because its safety has not been established in these populations
Symptoms include dizziness, sweating, confusion, and, in severe cases, loss of consciousness
Growth of infants with neonatal growth hormone deficiency